PT - JOURNAL ARTICLE AU - Jacob McCright AU - Colin Skeen AU - Jenny Yarmovsky AU - Katharina Maisel TI - Dense poly(ethylene glycol) coatings maximize nanoparticle transport across lymphatic endothelial cells and accumulate in the skindraining lymph nodes AID - 10.1101/2020.08.01.232249 DP - 2022 Jan 01 TA - bioRxiv PG - 2020.08.01.232249 4099 - http://biorxiv.org/content/early/2022/01/27/2020.08.01.232249.short 4100 - http://biorxiv.org/content/early/2022/01/27/2020.08.01.232249.full AB - Lymphatic vessels have recently been shown to effectively deliver immune modulatory therapies to the lymph nodes, which enhances their therapeutic efficacy. Prior work has shown that lymphatics transport 10–250 nm nanoparticles from peripheral tissues to the lymph node. However, the surface chemistry required to maximize this transport is poorly understood. Here, we determined the effect of surface poly(ethylene glycol) (PEG) density and size on nanoparticle transport across lymphatic endothelial cells (LECs) by differentially PEGylated model polystyrene nanoparticles. Using an established in-vitro lymphatic transport model, we found PEGylation improved the transport of 100 and 40 nm nanoparticles across LECs 50-fold compared to the unmodified nanoparticles and that transport is maximized when the PEG is in a dense brush conformation or high grafting density (Rf/D = 4.9). We also determined that these trends are not size-dependent. PEGylating 40 nm nanoparticles improved transport efficiency across LECs 68-fold compared to unmodified nanoparticles. We also found that PEGylated 100 nm and 40 nm nanoparticles accumulate in lymph nodes within 4 hours after intradermal injection, while unmodified nanoparticles accumulated minimally. Dense PEGylation also led nanoparticles to travel the furthest distance from the injection site. Finally, we determined that nanoparticles are transported via both paracellular and transcellular mechanisms, and that PEG conformation modulates the cellular transport mechanisms. Our results suggest that PEG conformation is crucial to maximize nanoparticle transport across LECs and into lymphatic vessels, making PEG density a crucial design. Optimizing PEG density on nanoparticle formulations has the potential to enhance immunotherapeutic and vaccine outcomes.Competing Interest StatementThe authors have declared no competing interest.LNlymph nodePEGpoly(ethylene glycolPSPolystyrenePLGApoly(lactic-co-glycolic acidDIDeionizedDLSdynamic light scatteringPDIpolydispersity indexPALSphase analysis light scatteringRfFlory radiusDgrafting distanceLECslymphatic endothelial cells